Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abraxane approved in Japan for additional indications

Feb. 21, 2013

Intramuscular formulations of Leunase approved in Japan

Feb. 21, 2013

Dacomitinib proves effective in bladder cancer models

Feb. 21, 2013

Array BioPharma and Genentech patent novel ERK inhibitors

Feb. 21, 2013

CEP-11981 demonstrates activity against urothelial carcinoma in mice

Feb. 21, 2013

Puma reaches SPA agreement for phase III trial in HER2-positive metastatic breast cancer

Feb. 21, 2013

Treatment begins in AEZS-108 study in triple-negative breast cancer

Feb. 21, 2013

Researchers at Gerinda Therapeutics disclose novel protein kinase inhibitors

Feb. 21, 2013

Beta Pharma presents new ALK/c-Met inhibitors

Feb. 21, 2013

Antiproliferative activity demonstrated for palbociclib in RCC cells

Feb. 20, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Other news to note for July 27, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Genmab, Merck, Par, Thyora.